Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ASEP Medical HoldingsXCNQ:ASEP 19 Pretax Margin % is -401.37% as of Mar. 2026. GuruFocus rates XCNQ:ASEP with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 942 Biotechnology companies, ASEP Medical Holdings ranks worse than 83.86% on this metric.
The historical rank and industry rank for ASEP Medical Holdings's Pretax Margin % or its related term are showing as below:
XCNQ:ASEP'
s Pretax Margin % Range Over the Past 10 Years
Min: -44909.52 Med: -4598.66 Max: -2093.77
Current: -2093.77
XCNQ:ASEP's Pretax Margin % is ranked worse than 83.86% of 942
companies
in the Biotechnology industry
Industry Median: -89.895
vs XCNQ:ASEP: -2093.77
ASEP Medical Holdings (XCNQ:ASEP) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
ASEP Medical Holdings Pretax Margin % Related Terms
ASEP Medical Holdings Pretax Margin % Historical Data
* Premium members only.
The historical data trend for ASEP Medical Holdings's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XCNQ:ASEP vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, ASEP Medical Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASEP Medical Holdings Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where ASEP Medical Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASEP Medical Holdings (XCNQ:ASEP) has a Pretax Margin % of -401.37% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #790 out of 942 companies in the Biotechnology industry, placing it in the top 83.9%.
Is ASEP Medical Holdings' Pretax Margin % too high?
ASEP Medical Holdings' current Pretax Margin % is -401.37%. Based on the distribution chart, ASEP Medical Holdings ranks #790 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #790 out of 942 companies for Pretax Margin %. This places ASEP Medical Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current Pretax Margin % is -401.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (XCNQ:ASEP) has a current Pretax Margin % of -401.37%. The current Pretax Margin % is -401.37%. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For ASEP Medical Holdings (XCNQ:ASEP), the current Pretax Margin % is -401.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score
Get the complete analysis for XCNQ:ASEP
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:ASEP has been successfully added to your 
